Related Experiment Video
Updated: May 28, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Incorporating model uncertainty in detecting rare variants: the Bayesian risk index
Melanie A Quintana1, Jonine L Berstein, Duncan C Thomas
1Department of Preventive Medicine, Division of Biostatistics, University of Southern California, Los Angeles, California, USA. wilsonme@usc.edu
This study introduces a new Bayesian framework to analyze rare genetic variants, improving the detection of disease risk associations and identifying specific variants driving these risks.
Area of Science:
- Genetics
- Statistical genetics
- Bioinformatics
Background:
- Rare genetic variants with low minor allele frequencies pose challenges for traditional association studies.
- Existing methods often lack the power to detect associations involving multiple rare variants within a genomic region.
- Common genetic markers may not capture the full spectrum of rare variant associations with disease risk.
Purpose of the Study:
- To develop and validate a novel analytical framework for investigating the aggregate and specific effects of multiple rare variants within genomic regions.
- To enhance the statistical power for detecting associations between rare variants and disease risk.
- To identify specific rare variants contributing to disease risk within associated regions.
Main Methods:
- A Bayesian approach is employed to construct a risk index based on multiple rare variants.
- Model uncertainty is incorporated for variant selection and effect direction.
- The framework allows for both group-level and variant-specific inference.
Main Results:
- Simulations demonstrate that the proposed methodology exhibits increased power compared to popular rare variant analysis methods for detecting global associations.
- The approach successfully identifies specific variants driving regional associations.
- The method was applied to sequence data from the WECARE Study of second primary breast cancers.
Conclusions:
- The novel Bayesian framework offers enhanced power for detecting rare variant associations with disease risk.
- This approach provides a robust method for identifying specific genetic variants contributing to disease.
- The methodology is applicable to real-world genetic sequence data, advancing the study of complex diseases.
Related Concept Videos
Uncertainty: Confidence Intervals
Propagation of Uncertainty from Random Error
Relative Risk
Propagation of Uncertainty from Systematic Error
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Confidence Intervals
A confidence...

